Cargando…
Impact of HOXB4 and PRDM16 Gene Expressions on Prognosis and Treatment Response in Acute Myeloid Leukemia Patients
INTRODUCTION: Acute myeloid leukemia (AML) is the most common type of leukemia among adults and is characterized by various genetic abnormalities. HOXB4 and PRDM16 are promising markers of AML. Our objective is to assess the potential roles of HOXB4 and PRDM16 as prognostic and predictive markers in...
Autores principales: | El-Meligui, Yomna M, Hassan, Naglaa M, Kassem, Amira B, Gouda, Nora A, Mohanad, Marwa, Hamouda, Manal A, Salahuddin, Ahmad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9241994/ https://www.ncbi.nlm.nih.gov/pubmed/35782688 http://dx.doi.org/10.2147/PGPM.S368640 |
Ejemplares similares
-
Correlation Study on HLA-DR and CD117 (c-Kit) Expressions: Its Prognosis and Treatment Response in Acute Myeloid Leukemia Patients
por: El-Meligui, Yomna M, et al.
Publicado: (2021) -
Combined Expression of CD34 and FLT3-Internal Tandem Duplication Mutation Predicts Poor Response to Treatment in Acute Myeloid Leukemia
por: Abdellateif, Mona S, et al.
Publicado: (2020) -
The Meningioma 1 (MN1) Gene is an Independent Poor Prognostic Factor in Adult Egyptian Acute Myeloid Leukemia Patients
por: Shafik, Roxan E, et al.
Publicado: (2017) -
SUMOylation of sPRDM16 promotes the progression of acute myeloid leukemia
por: Dong, Song, et al.
Publicado: (2015) -
The Prognostic Value and Function of HOXB5 in Acute Myeloid Leukemia
por: Chen, Miao, et al.
Publicado: (2021)